Brief: Scope Fluidics Plans To Complete Clinical Certification Tests For PCR|ONE Panel In Q1 2021
04/12/2020 07:48
Dec 4 (Reuters) - Scope Fluidics SA SCPP.WA :
* PLANS TO COMPLETE CLINICAL CERTIFICATION TESTS FOR PCR|ONE
SARS-COV-2 PANEL, BOTH CE-IVD AND FDA EUA IN Q1 2021
Source text for Eikon: ID:nEM7FlXhta
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project